Merrion Pharmaceuticals : Annual Report and Notice of AGM and EGM

18 June 2014

Annual Report and Notice of AGM and EGM

Merrion Pharmaceuticals plc (the "Company") confirms that the Annual Report and Accounts for the year ended 31 December 2013 (the "2013 Annual Report and Accounts"), the Notice of the Annual General Meeting ("AGM") and the Notice of an Extraordinary General Meeting ("EGM") have been posted to shareholders.

The AGM is to be held on Wednesday 16 July 2014 at 10:00 am at the offices of ByrneWallace, 88 Harcourt Street, Dublin 2, Ireland. The EGM will be held at the offices of ByrneWallace, 88 Harcourt Street, Dublin 2, Ireland at 10:15 am on Wednesday 16th July 2014 or immediately after the conclusion of the AGM.

The purpose of the EGM is as follows:

In accordance with Section 40 of the Companies (Amendment) Act 1983 to consider whether any, and if so what, measures should be taken to deal with the situation which has arisen whereby the Company's net assets are half or less of the amount of the Company's called-up share capital.

A copy of the 2013 Annual Report and Accounts and Notices of AGM and EGM are available on the Company's website: www.merrionpharma.com

For reference: 

Investor Enquiries: Merrion Pharmaceuticals Plc. John Fox T [phone] www.merrionpharma.com	Media Enquiries: Dempsey Corporate Conor Dempsey T [phone] Email:[e-mail]
Davy Corporate Finance Ivan Murphy/Anthony Farrell T [phone]